Details of the Settlement
The $45 million settlement with CVS is a crucial step in Baltimore’s efforts to address the opioid crisis. This agreement follows a similar settlement with Allergan Finance earlier this year, bringing the total amount recovered to $90 million. The funds from these settlements will be allocated to various community programs, including the Law Enforcement Assisted Diversion program, Healing City Baltimore, Roberta’s House, and Prison Cells to PhD. These initiatives aim to provide support and resources to those affected by the opioid epidemic.
Mayor Brandon Scott highlighted the importance of these settlements in holding pharmaceutical companies accountable. He stated that these companies prioritized profits over the health and safety of Baltimore’s residents, and the city is committed to ensuring they pay their fair share to repair the damage caused. The settlement with CVS also includes provisions for promoting safer drug distribution practices to prevent future crises.
The settlement with CVS is part of a broader strategy by Baltimore to seek justice for the harm caused by the opioid epidemic. The city has opted out of global settlements to pursue its own litigation, resulting in more substantial recoveries. This approach has proven successful, with the city recovering more funds than it would have under the global settlements.
Impact on the Community
The funds from the settlements will have a significant impact on Baltimore’s efforts to combat the opioid crisis. The Law Enforcement Assisted Diversion program will receive $5 million to train police officers in handling drug-use incidents without resorting to arrests. This program aims to reduce the criminalization of drug users and provide them with the support they need to recover. Healing City Baltimore, a community advocacy organization, will also receive $5 million to continue its work in promoting healing and resilience in the community.
Roberta’s House, a family grief support center, will receive $1 million to expand its services to families affected by the opioid crisis. This funding will enable the center to provide more comprehensive support to those dealing with the loss of loved ones due to opioid overdoses. Additionally, Prison Cells to PhD, a community reintegration organization, will receive $1 million to help formerly incarcerated individuals reintegrate into society and reduce recidivism rates.
These programs are essential in addressing the multifaceted impact of the opioid crisis on Baltimore’s communities. By providing support and resources to those affected, the city aims to promote recovery and resilience. The funds from the settlements will enable these programs to expand their reach and effectiveness, ultimately contributing to a healthier and safer Baltimore.
Future Litigation and Goals
Baltimore’s legal team is continuing its efforts to hold other pharmaceutical companies accountable for their role in the opioid crisis. The city has built a strong case against several other companies and is prepared to take them to trial if necessary. City Solicitor Ebony Thompson emphasized the city’s commitment to seeking justice and ensuring that all responsible parties are held accountable.
The funds recovered from these settlements will be used to support ongoing and future initiatives aimed at combating the opioid crisis. The city plans to invest in prevention, treatment, and recovery programs to address the root causes of the epidemic. This comprehensive approach is designed to provide long-term solutions and reduce the impact of the opioid crisis on Baltimore’s communities.
Mayor Brandon Scott reiterated the city’s dedication to using the recovered funds effectively. He stated that every penny will be put to its most effective use to combat the opioid epidemic at all levels. The city’s strategy of pursuing its own litigation has proven successful, and Baltimore is committed to continuing this approach to achieve justice for its residents.
Comments